Decoy Therapeutics Inc. (DCOY) — Institutional Holders, Q2 2026
4 institutional investment managers reported a DCOY position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $31.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DCOY in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- VANGUARD CAPITAL MANAGEMENTNew · +4,034 sh+$29.0K
- Caitong International Asset Management , LtdNew · +2 sh+$14.00
Biggest sellers
- Tower Research Capital (TRC)Trimmed · -765 sh-$5.5K
- UBS Group AGTrimmed · -521 sh-$3.7K
- Advisory Services NetworkSold out · -41 sh-$295.00
- MORGAN STANLEYSold out · -1 sh-$7.00
DCOY 13F holders ranked 1–4 of 4
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 4,034 sh | 4,034 | $29.0K | 0.00% | New |
| 2 | Tower Research Capital (TRC)#2 · 256 sh | 256 | $1.8K | 0.00% | -74.9% |
| 3 | UBS Group AG#3 · 25 sh | 25 | $180.00 | 0.00% | -95.4% |
| 4 | Caitong International Asset Management , Ltd#4 · 2 sh | 2 | $14.00 | 0.00% | New |
Funds that sold out of DCOY in Q2 2026 (2)
Held DCOY at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Advisory Services Network41 sh | 41 | $268.00 |
| MORGAN STANLEY1 sh | 1 | $7.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.